| abstract |
The invention relates to compounds of the formula (I): (see formula (I)) and its salts, to a process for its manufacture, to its use in the treatment of diseases (especially cysteine protease dependent, such as UCH -L3 and / or USP-2), or for the manufacture of pharmaceutical formulations against these diseases; to methods for treating warm-blooded animals, which comprise administering the compounds and / or their salts, to said animals; and to pharmaceutical preparations, especially for the treatment of diseases, which comprise the compounds and / or their salts. |